Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 3-4/2014

01.02.2014 | original article

COPD: an underdiagnosed disease at hospital environment

verfasst von: MD Prof. Dr. Levent Kart, MD Muhammed Emin Akkoyunlu, MD Mehmet Bayram, MD Fatih Yakar, MD Hatice Kutbay Özçelik, MD Fatmanur Karaköse, MD Assoc. Prof. Murat Sezer

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background and Aim

Chronic obstructive pulmonary disease (COPD) is a serious disease with morbidity and mortality due to delayed diagnosis until significant symptoms arise. We aimed to assess the utility of spirometry and COPD Assessment Test (CAT) in detecting undiagnosed COPD patients in a localized area.

Material and Methods

People who came to the hospital for patient visit or examination with a smoking history of > 10 pack-years (> 40 years old), and with no known chest disease were invited to study. The participants completed a questionnaire and performed spirometry. Spirometry was performed according to ATS/ERS Task Force on spirometry. COPD was defined as according to the Global Initiative for Chronic Obstructive Lung Disease guidelines.

Results

There were 800 subjects screened, and 648, capable of performing spirometry, were included to the study. The mean age was 48.3 ± 9.0 and 38 % of the study population was male. Post-bronchodilator FEV1/FVC ratio was lower than 0.70 in 17 % of the subjects. Median (25–75 percentiles) total CAT scores and among the questions of CAT; cough, phlegm, chest tightness and breathlessness scores for COPD and non-COPD subjects were; 15(9–22) vs 12(6–18) (p  = .004), 2(1–3) vs 1(0–2) (p  < .001), 2(0–3) vs 1(0–3) (p  = .004), 3(1–4) vs 2(0–3) (p  > .001), 4(3–5) vs 3(2–4) (p  = .001), respectively. Symptom prevalence was as follows: exertional dyspnea 91 %, dyspnea 80.9 %, cough 56.3 % and phlegm 58.3 % in COPD.

Conclusion

Our study showed that spirometric screening together with the CAT questionnaire may improve the awareness of disease and may determine undiagnosed patients.
Literatur
1.
Zurück zum Zitat Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374:721–32. PubMedCrossRef Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374:721–32. PubMedCrossRef
2.
Zurück zum Zitat Lin K, Watkins B, Jonson T, Rodriguez JA, Barton MB. U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S Preventive Services Task Force. Ann Intern Med. 2008;148(7):535–43. PubMedCrossRef Lin K, Watkins B, Jonson T, Rodriguez JA, Barton MB. U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S Preventive Services Task Force. Ann Intern Med. 2008;148(7):535–43. PubMedCrossRef
3.
Zurück zum Zitat Bednarek M, Meciejewsky J, Wozniak M, Kuca P, Zielinski J. Prevalence severity and underdiagnosis of COPD primary care settings. Thorax 2008;63(5):402–7. PubMedCrossRef Bednarek M, Meciejewsky J, Wozniak M, Kuca P, Zielinski J. Prevalence severity and underdiagnosis of COPD primary care settings. Thorax 2008;63(5):402–7. PubMedCrossRef
4.
Zurück zum Zitat Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54. PubMedCrossRef Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54. PubMedCrossRef
5.
Zurück zum Zitat Reliability and validity of Turkish version of COPD assessment test. Yorgancıogˇlu A, Polatlı M, Aydemir Ö, Yılmaz Demirci N, Kırkıl G, Naycı Atıs¸ S et al. Tuberk Toraks. 2012;60(4):314–20. Reliability and validity of Turkish version of COPD assessment test. Yorgancıogˇlu A, Polatlı M, Aydemir Ö, Yılmaz Demirci N, Kırkıl G, Naycı Atıs¸ S et al. Tuberk Toraks. 2012;60(4):314–20.
6.
Zurück zum Zitat Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J. 2003 Sep;22(3):462–9. PubMedCrossRef Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J. 2003 Sep;22(3):462–9. PubMedCrossRef
7.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force: Standardisation Of Spirometry. Eur Respir J. 2005;26:319–38. PubMedCrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force: Standardisation Of Spirometry. Eur Respir J. 2005;26:319–38. PubMedCrossRef
8.
Zurück zum Zitat Global strategy for diagnosis management, and prevention of COPD, update December 2010. Global Initiative for Chronic obstructive lung disease; 2010. from http://​goldcopd.​com/​. Accessed: 10. Aug. 2011. Global strategy for diagnosis management, and prevention of COPD, update December 2010. Global Initiative for Chronic obstructive lung disease; 2010. from http://​goldcopd.​com/​. Accessed: 10. Aug. 2011.
9.
Zurück zum Zitat Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741–50. PubMedCrossRef Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741–50. PubMedCrossRef
10.
Zurück zum Zitat Nelson SB, LaVange LM, Nie Y, Wals JW, Enright PL, Martinez FJ, et al. Questionnaires and Pocket Spirometers Provide an Alternative Approach for COPD Screening in the General Population. Chest 2012;142:358–66. PubMedCrossRef Nelson SB, LaVange LM, Nie Y, Wals JW, Enright PL, Martinez FJ, et al. Questionnaires and Pocket Spirometers Provide an Alternative Approach for COPD Screening in the General Population. Chest 2012;142:358–66. PubMedCrossRef
12.
Zurück zum Zitat Zielinski J, Bednarek M. Early detection of COPD in high-risk population using spirometric screening. Chest. 2001; 119(3):731–736. PubMedCrossRef Zielinski J, Bednarek M. Early detection of COPD in high-risk population using spirometric screening. Chest. 2001; 119(3):731–736. PubMedCrossRef
13.
Zurück zum Zitat Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM. Spirometry as a motivation tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res. 2007;9(1):21–32 PubMedCrossRef Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM. Spirometry as a motivation tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res. 2007;9(1):21–32 PubMedCrossRef
14.
Zurück zum Zitat Leuppi JD, Miedinger D, Chhajed PN, Buess C, Schafroth S, Bucher HC, et al. Quality of spirometry in primary care of case finding of airway obstruction in smokers. Respiration. 2010;79(6):469–74 PubMedCrossRef Leuppi JD, Miedinger D, Chhajed PN, Buess C, Schafroth S, Bucher HC, et al. Quality of spirometry in primary care of case finding of airway obstruction in smokers. Respiration. 2010;79(6):469–74 PubMedCrossRef
15.
Zurück zum Zitat Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61:869–873. PubMedCentralPubMedCrossRef Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61:869–873. PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Vollmer WM, Gíslason T, Burney P, Enright PL, Gulsvik A, Kocabas A, et al. Comparison of spirometry criteriafor the diagnoses of COPD: Results of from the BOLD study Eur Resp J 2009;34:588–97. Vollmer WM, Gíslason T, Burney P, Enright PL, Gulsvik A, Kocabas A, et al. Comparison of spirometry criteriafor the diagnoses of COPD: Results of from the BOLD study Eur Resp J 2009;34:588–97.
17.
Zurück zum Zitat Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22:268–273. PubMedCrossRef Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22:268–273. PubMedCrossRef
18.
Zurück zum Zitat Buist AS, Vollmer WM, Sullivan S, Weiss KB, Lee TA, Menezes AM, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277–83. PubMedCrossRef Buist AS, Vollmer WM, Sullivan S, Weiss KB, Lee TA, Menezes AM, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277–83. PubMedCrossRef
19.
Zurück zum Zitat Dongel I, Bayram M, Bakan ND, Yalcin H, Gulturk S. Is living close to ophiolites related to asbestos related diseases? Cross-sectional study. Respir Med 2013;107:870–74 PubMedCrossRef Dongel I, Bayram M, Bakan ND, Yalcin H, Gulturk S. Is living close to ophiolites related to asbestos related diseases? Cross-sectional study. Respir Med 2013;107:870–74 PubMedCrossRef
20.
Zurück zum Zitat Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study Eur Respir J. 2011 Jul;38(1):29–35. PubMedCrossRef Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study Eur Respir J. 2011 Jul;38(1):29–35. PubMedCrossRef
21.
Zurück zum Zitat Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary diseases in general practice: cross sectional case finding study. Br Med J.2002;324:1370–73. CrossRef Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary diseases in general practice: cross sectional case finding study. Br Med J.2002;324:1370–73. CrossRef
22.
Zurück zum Zitat Raghavan N, Lam YM, Webb KA, Guenette JA, Amornputtisathaporn N, Raghavan R, et al. Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD. 2012;9(2):175–83. PubMedCrossRef Raghavan N, Lam YM, Webb KA, Guenette JA, Amornputtisathaporn N, Raghavan R, et al. Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD. 2012;9(2):175–83. PubMedCrossRef
23.
Zurück zum Zitat Hanania NA, Manniono DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, et al. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFG). Respir med 2010;104(8):1160–70. Hanania NA, Manniono DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, et al. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFG). Respir med 2010;104(8):1160–70.
Metadaten
Titel
COPD: an underdiagnosed disease at hospital environment
verfasst von
MD Prof. Dr. Levent Kart
MD Muhammed Emin Akkoyunlu
MD Mehmet Bayram
MD Fatih Yakar
MD Hatice Kutbay Özçelik
MD Fatmanur Karaköse
MD Assoc. Prof. Murat Sezer
Publikationsdatum
01.02.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0458-4